Trinity Biotech (TRIB) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free TRIB Stock Alerts $1.83 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Trinity Biotech Short Interest DataCurrent Short Volume1,900 sharesPrevious Short Volume1,200 sharesChange Vs. Previous Month+58.33%Dollar Volume Sold Short$3,629.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares7,620,000 sharesFloat Size7,370,000 sharesShort Percent of Float0.03%Today's Trading Volume12,497 sharesAverage Trading Volume78,224 sharesToday's Volume Vs. Average16% Short Selling Trinity Biotech ? Sign up to receive the latest short interest report for Trinity Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTRIB Short Interest Over TimeTRIB Days to Cover Over TimeTRIB Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Trinity Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,900 shares $3,629.00 +58.3%0.0%0 $1.91 3/31/20241,200 shares $2,448.00 -72.1%0.0%0 $2.04 3/15/20244,300 shares $9,718.00 -71.9%0.1%0 $2.26 2/29/202415,300 shares $33,354.00 -5.0%0.2%0.2 $2.18 2/15/202416,100 shares $41,135.50 -46.9%N/A0.2 $2.56 1/31/202430,300 shares $17,877.00 +3.1%N/A0.1 $0.59 Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/202429,400 shares $14,112.00 +92.2%N/A0.6 $0.48 12/31/202315,300 shares $6,563.70 -72.6%N/A0.3 $0.43 12/15/202355,800 shares $27,844.20 -14.6%N/A1.2 $0.50 11/30/202365,300 shares $31,148.10 +9.4%N/A1.8 $0.48 11/15/202359,700 shares $25,611.30 +70.1%N/A2.2 $0.43 10/31/202335,100 shares $16,146.00 +9.4%N/A1.3 $0.46 10/15/202332,100 shares $16,820.40 +23.0%N/A0.8 $0.52 9/30/202326,100 shares $19,186.11 +6.1%N/A0.6 $0.74 9/15/202324,600 shares $17,736.60 -1.6%N/A0.4 $0.72 8/31/202325,000 shares $20,000.00 +20.2%N/A0.4 $0.80 8/15/202320,800 shares $14,913.60 -59.9%N/A0.3 $0.72 7/31/202351,800 shares $49,210.00 +3.2%N/A0.8 $0.95 7/15/202350,200 shares $42,670.00 +27.4%N/A0.8 $0.85 6/30/202339,400 shares $37,473.34 -8.4%N/A0.8 $0.95 6/15/202343,000 shares $44,720.00 +91.1%N/A1 $1.04 5/31/202322,500 shares $20,925.00 -23.5%N/A0.5 $0.93 5/15/202329,400 shares $27,606.60 -18.3%N/A0.8 $0.94 4/30/202336,000 shares $37,972.80 -6.7%N/A1.1 $1.05 4/15/202338,600 shares $32,427.86 +33.1%N/A1.3 $0.84 3/31/202329,000 shares $27,260.00 -23.1%N/A1.2 $0.94 3/15/202337,700 shares $36,188.23 +10.9%N/A1.5 $0.96 2/28/202334,000 shares $35,870.00 -11.9%N/A1.3 $1.06 2/15/202338,600 shares $41,109.00 -1.5%N/A1.5 $1.07 1/31/202339,200 shares $42,140.00 -35.3%N/A1.3 $1.08 1/15/202360,600 shares $64,236.00 -19.8%N/A1.8 $1.06 12/30/202275,600 shares $74,844.00 -5.4%N/A2.3 $0.99 12/15/202279,900 shares $92,684.00 -23.8%N/A2.4 $1.16 11/30/2022104,900 shares $139,517.00 -22.0%N/A3.2 $1.33 11/15/2022134,400 shares $178,752.00 -2.9%N/A3.7 $1.33 10/31/2022138,400 shares $160,544.00 -17.1%N/A4.2 $1.16 10/15/2022166,900 shares $198,627.69 -12.7%N/A4.7 $1.19 9/30/2022191,200 shares $204,775.20 -12.1%N/A5.2 $1.07 9/15/2022217,400 shares $256,532.00 -13.9%N/A5.3 $1.18 8/31/2022252,500 shares $308,050.00 -13.4%N/A5.8 $1.22Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> TRIB Short Interest - Frequently Asked Questions What is Trinity Biotech's current short interest? Short interest is the volume of Trinity Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,900 shares of TRIB short. 0.03% of Trinity Biotech's shares are currently sold short. Learn More on Trinity Biotech's current short interest. Which institutional investors are shorting Trinity Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trinity Biotech: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Trinity Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of Trinity Biotech's floating shares are currently sold short. Is Trinity Biotech's short interest increasing or decreasing? Trinity Biotech saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,900 shares, an increase of 58.3% from the previous total of 1,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Trinity Biotech's float size? Trinity Biotech currently has issued a total of 7,620,000 shares. Some of Trinity Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trinity Biotech currently has a public float of 7,370,000 shares. How does Trinity Biotech's short interest compare to its competitors? 0.03% of Trinity Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Trinity Biotech: Biomerica, Inc. (0.39%), Cardio Diagnostics Holdings, Inc. (2.91%), OncoCyte Co. (3.08%), MyMD Pharmaceuticals, Inc. (20.58%), ImmuCell Co. (0.08%), Aspira Women's Health Inc. (2.52%), ARCA biopharma, Inc. (39.55%), PetVivo Holdings, Inc. (1.49%), ABVC BioPharma, Inc. (6.14%), Edesa Biotech, Inc. (0.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Trinity Biotech stock? Short selling TRIB is an investing strategy that aims to generate trading profit from Trinity Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trinity Biotech? A short squeeze for Trinity Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRIB, which in turn drives the price of the stock up even further. How often is Trinity Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRIB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Biomerica Short Interest Data Cardio Diagnostics Short Interest Data OncoCyte Short Interest Data MyMD Pharmaceuticals Short Interest Data ImmuCell Short Interest Data Aspira Women's Health Short Interest Data ARCA biopharma Short Interest Data PetVivo Short Interest Data ABVC BioPharma Short Interest Data Edesa Biotech Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRIB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press